Company: PMVP
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030414
Chunk: 2

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 15
Chunk 2
---
 10.12+
     
    Consulting Agreement, dated January 1, 2016, by and between the Registrant and Arnold Levine, Ph.D.
     
    S-1
     
    333-248627
     
    10.16
     
    September 4, 2020

    10.13+
     
    Consulting Agreement, dated May 21, 2021, by and between the Registrant and Richard Heyman, Ph.D., as amended on July 16, 2021.
     
    10-K
     
    001-39539
     
    10.17
     
    March 1, 2022

    10.14
     
    Lease Termination Agreement, dated August 5, 2024, by and between BMR-One Research Way LLC and PMV Pharmaceuticals, Inc.
     
    8-K
     
    001-39539
     
    10.1
     
    August 8, 2024

    10.15
     
    Open Market Sale Agreement, dated as of October 4, 2021, between the Registrant and Jefferies LLC.
     
    S-3ASR
     
    333-260012
     
    1.2
     
    October 4, 2021

    10.16+
     
    Amended and Restated Employment Letter, dated January 5, 2024, by and between the Registrant and Michael Carulli.
     
    10-K
     
    001-39539
     
    10.22
     
    February 29, 2024

    10.17+
     
    Consulting Agreement, dated February 13, 2024, by and between the Registrant and Charles Baum, MD., Ph.D.
     
    10-K
     
    001-39539
     
    10.23
     
    February 29, 2024

    10.18+
     
    Amended and Restated Change in Control and Severance Policy Participation Agreement, dated January 5, 2024, by and between the Registrant and Michael Carulli.
     
    10-K
     
    001-39539
     
    10.24
     
    February